Streetwise Reports Examines the Commercial Launch Planned for Schizophrenia Drug
January 24, 2019 07:00 ET
|
Streetwise Reports Llc
SAN FRANCISCO, Jan. 24, 2019 (GLOBE NEWSWIRE) -- DURECT Corp. (DRRX:NASDAQ), a biopharmaceutical company, noted that Indivior Plc announced that it will launch in the U.S. its drug for the treatment...
Streetwise Reports Examines How One Analyst Says This Biotech Company Could Potentially 'Double'
November 15, 2017 09:00 ET
|
Streetwise Reports Llc
SAN FRANCISCO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Analyst Grant Zeng of Zacks Small Cap Research examines what transpired with this biopharmaceutical company during Q3/17. Included in this article...